用于移植治疗心脏疾病的干细胞主要有胚胎干细胞、骨骼肌卫星细胞和骨髓间充质干细胞(MSCs).在心肌梗死治疗中,有学者发现MSCs移植后能改善心肌梗死后心律失常的发生.MSCs移植最基本的治疗机制是替代功能受损或已死亡的心肌细胞,发挥其相应的功能.MSCs移植定位、分化均一性及与宿主心肌细胞整合问题等均有待解决.中文核心期刊要目总览(PKU)中国科技核心期刊(ISTIC)0116-182
Cardiac arrhythmias are a major cause of death and disability. A large number of experimental cell a...
Summary: To assess the utility of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-...
Human embryonic stem cell-derived cardiomyocytes (hESC-CM) have been proposed as a new model for saf...
诱导多能干细胞技术的出现,第一次将终末分化的人体细胞重新编程为具有多种分化潜能的多能干细胞,使干细胞研究得以避开伦理学问题,为将干细胞应用于疾病的研究提供了新的方向.随着Moretti和Itzhaki...
Stem cell therapy appears to be a promising modality formyocardial repair of both hearts that are po...
Stem cell therapy is an emerging therapeutic approach for the treatment of cardiovascular diseases. ...
研究種目：若手研究研究期間：2019～2020課題番号：19K17555研究代表者：小林 秀樹研究者番号：９０７９４３８９Other2019～2020年度科学研究費助成事業（若手研究研究成果報告書 課...
近年来心律失常的诊断进展主要是无创心脏电生理技术领域的进展,包括12导联动态心电图、微型心电图监测仪、心室晚电位检测、倾斜试验、心率变异性、QT离散度和T波交替分析等.其治疗方面主要是药物治疗心房颤动...
Abstract—So far, the major safety issue raised by the use of stem cells for cardiac repair has been ...
在心律失常的药物治疗中,抗心律失常药物虽然有效,但并不理想,且很多不良反应和并发症让人难以接受.如何使心律失常患者得到安全、有效的药物治疗,是人们长久以来探索的方向.现已发现,针对高血压、冠心病、心力...
There has been repeated concern that intramyocardial (i.m.) delivery of cells could cause ventricula...
遗传性心律失常是环境因素和遗传因素共同作用的结果.对于患有遗传性心律失常家系的成员来说,遗传因素可以作用在传导系统的不同层面.目前,虽然已确立了很多心律失常的遗传模式,但致病基因的确立为数不多.本文将...
Human embryonic stem cell-derived cardiomyocytes (hESC-CM) have been proposed as a new model for saf...
Giada CattelanUniversität Innsbruck, Masterarbeit, 2018Eurac Research, Masterarbeit, 2018(VLID)26053...
Cardiac arrhythmias are a major cause of death and disability. A large number of experimental cell a...
Cardiac arrhythmias are a major cause of death and disability. A large number of experimental cell a...
Summary: To assess the utility of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-...
Human embryonic stem cell-derived cardiomyocytes (hESC-CM) have been proposed as a new model for saf...
诱导多能干细胞技术的出现,第一次将终末分化的人体细胞重新编程为具有多种分化潜能的多能干细胞,使干细胞研究得以避开伦理学问题,为将干细胞应用于疾病的研究提供了新的方向.随着Moretti和Itzhaki...
Stem cell therapy appears to be a promising modality formyocardial repair of both hearts that are po...
Stem cell therapy is an emerging therapeutic approach for the treatment of cardiovascular diseases. ...
研究種目：若手研究研究期間：2019～2020課題番号：19K17555研究代表者：小林 秀樹研究者番号：９０７９４３８９Other2019～2020年度科学研究費助成事業（若手研究研究成果報告書 課...
近年来心律失常的诊断进展主要是无创心脏电生理技术领域的进展,包括12导联动态心电图、微型心电图监测仪、心室晚电位检测、倾斜试验、心率变异性、QT离散度和T波交替分析等.其治疗方面主要是药物治疗心房颤动...
Abstract—So far, the major safety issue raised by the use of stem cells for cardiac repair has been ...
在心律失常的药物治疗中,抗心律失常药物虽然有效,但并不理想,且很多不良反应和并发症让人难以接受.如何使心律失常患者得到安全、有效的药物治疗,是人们长久以来探索的方向.现已发现,针对高血压、冠心病、心力...
There has been repeated concern that intramyocardial (i.m.) delivery of cells could cause ventricula...
遗传性心律失常是环境因素和遗传因素共同作用的结果.对于患有遗传性心律失常家系的成员来说,遗传因素可以作用在传导系统的不同层面.目前,虽然已确立了很多心律失常的遗传模式,但致病基因的确立为数不多.本文将...
Human embryonic stem cell-derived cardiomyocytes (hESC-CM) have been proposed as a new model for saf...
Giada CattelanUniversität Innsbruck, Masterarbeit, 2018Eurac Research, Masterarbeit, 2018(VLID)26053...
Cardiac arrhythmias are a major cause of death and disability. A large number of experimental cell a...
Cardiac arrhythmias are a major cause of death and disability. A large number of experimental cell a...
Summary: To assess the utility of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-...
Human embryonic stem cell-derived cardiomyocytes (hESC-CM) have been proposed as a new model for saf...
DOI
Add to ORKG